All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: ORF10

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	39584063	G29543T	ORF10	ORF10		R	View
2	39584063	G29742T	ORF10	ORF10		R	View
3	39584063	T29834A	ORF10	ORF10		R	View
4	37275159	L37F	ORF10	ORF10	COVID-19	G R S C L	View
5	37520374	T38I	ORF10	ORF10	COVID-19	G	View
6	37744926	I27X	ORF10	ORF10	COVID-19	G R S C L	View
7	37573409	C29578A	ORF10	ORF10	COVID-19	G R S C L	View
8	36778569	V30L	ORF10	ORF10	COVID-19	G R S L	View
9	38605705	C29632T	ORF10	ORF10	COVID-19	G R S C L	View
10	40281619	L37F	ORF10	ORF10	COVID-19	C L	View
11	36090111	T60A	ORF10	ORF10	COVID-19	R C L	View
12	35614572	V30L	ORF10	ORF10	COVID-19	R	View
13	32300673	C29642T	ORF10	ORF10	COVID-19	R	View
14	34733263	V30L	ORF10	ORF10	COVID-19	R	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.